E-SELECTIN (CD62E) is an endothelial specific glycoprotein belonging to the selectin family of adhesion molecules. Because a high expression of this molecule at intestinal mucosal surfaces in inflammatory bowel disease (IBD) has been described earlier, the aim was to assess serum levels of E-selectin (sE-selectin) 
Introduction
The pathogenesis of the inflammatory bowel diseases (IBD), i.e. ulcerative colitis (UC) and Crohn's disease (CD), is not yet clarified. Among the mediators which in the view of recent research are thought to be of importance for the pathogenesis of these diseases are the adhesion molecules, and among them E-selectin (CD62E) (previously named ELAM-1, endothelial-leucocyte adhesion molecule-I) with a molecular weight of 115 kDa.
The E-selectin molecule is normally not present on the surfaces of vascular endothelial cells, but in vitro investigations have revealed that stimulation with certain cytokines (i.e. interleukin-1, tumour necrosis factor-0t, lipopolysaccharides, substance P, and interferon-g) induces production and expression of Eselectin on surfaces of such cells. [1] [2] [3] [4] [5] [6] [7] The amount of Eselectin increases shortly after stimulation with these cytokines, whereas it decreases after stimulation for [16] [17] [18] [19] [20] [21] [22] [23] [24] h. [4] [5] [6] [7] On the contrary, stimulation with TNFcontinuously increases production of E-selectin.: After epicutaneous provocation for 2 h in vivo with chemicals known to 4 Accordingly, electron microscopy has shown E-selectin to be exocytosed into the vascular lumen. 15 Therefore, it has been suggested that E-selectin is both a transmembrane protein and a secretory protein.
Antibodies to the E-selectin ligand, sLex, have been shown to react with venous endothelia of the inflamed appendix, 16 and an analogous mechanism of E-selectin directing leukocytes to inflamed bowel segments may occur in IBD.
The aims of this study was to examine: (1) 
